BioMaric

Foundation date

13/08/2001

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

BioMaric is a Belgian biotechnology company specialised in the development of diagnostic assays for infectious diseases (such as HIV, HCV and HTLV) used for blood bank screening and laboratory diagnostics.

Upcoming events

Latest news

  • ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder

    19 hours ago

  • Confo Therapeutics awarded EUR 1.7M VLAIO grant to expand application of ConfoBody┬« drug discovery and development technology in rare diseases

    Tuesday June 28th 2022

  • MRM Health starts clinical trial with next-generation optimized consortium therapeutic MH002 in Pouchitis

    Tuesday June 28th 2022